176 related articles for article (PubMed ID: 28126926)
1. Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes.
Yeh P; Dickinson M; Ftouni S; Hunter T; Sinha D; Wong SQ; Agarwal R; Vedururu R; Doig K; Fong CY; Blombery P; Westerman D; Dawson MA; Dawson SJ
Blood; 2017 Mar; 129(12):1685-1690. PubMed ID: 28126926
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes.
Suzuki Y; Tomita A; Nakamura F; Iriyama C; Shirahata-Adachi M; Shimada K; Akashi A; Ishikawa Y; Kaneda N; Kiyoi H
Cancer Sci; 2016 Sep; 107(9):1329-37. PubMed ID: 27323954
[TBL] [Abstract][Full Text] [Related]
3. Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome.
Hrustincova A; Krejcik Z; Kundrat D; Szikszai K; Belickova M; Pecherkova P; Klema J; Vesela J; Hruba M; Cermak J; Hrdinova T; Krijt M; Valka J; Jonasova A; Merkerova MD
Cells; 2020 Mar; 9(4):. PubMed ID: 32224889
[TBL] [Abstract][Full Text] [Related]
4. Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.
Calleja A; Yun S; Moreilhon C; Karsenti JM; Gastaud L; Mannone L; Komrokji R; Al Ali N; Dadone-Montaudie B; Robert G; Auberger P; Raynaud S; Sallman DA; Cluzeau T
Eur J Haematol; 2020 May; 104(5):488-498. PubMed ID: 31990086
[TBL] [Abstract][Full Text] [Related]
5. Nine years without a new FDA-approved therapy for MDS: how can we break through the impasse?
DeZern AE
Hematology Am Soc Hematol Educ Program; 2015; 2015():308-16. PubMed ID: 26637738
[TBL] [Abstract][Full Text] [Related]
6. [Study of the clonal origin and development of MDS by FISH analysis of dysplasia cells in bone marrow of patients with MDS].
Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):650-6. PubMed ID: 23815916
[TBL] [Abstract][Full Text] [Related]
7. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.
Nakamura S; Yokoyama K; Shimizu E; Yusa N; Kondoh K; Ogawa M; Takei T; Kobayashi A; Ito M; Isobe M; Konuma T; Kato S; Kasajima R; Wada Y; Nagamura-Inoue T; Yamaguchi R; Takahashi S; Imoto S; Miyano S; Tojo A
Blood; 2019 Jun; 133(25):2682-2695. PubMed ID: 30936070
[TBL] [Abstract][Full Text] [Related]
9. Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group.
Götze K; Platzbecker U; Giagounidis A; Haase D; Lübbert M; Aul C; Ganser A; Germing U; Hofmann WK
Ann Hematol; 2010 Sep; 89(9):841-50. PubMed ID: 20567826
[TBL] [Abstract][Full Text] [Related]
10. Array comparative genomic hybridization of peripheral blood granulocytes of patients with myelodysplastic syndrome detects karyotypic abnormalities.
Vercauteren SM; Sung S; Starczynowski DT; Lam WL; Bruyere H; Horsman DE; Tsang P; Leitch H; Karsan A
Am J Clin Pathol; 2010 Jul; 134(1):119-26. PubMed ID: 20551276
[TBL] [Abstract][Full Text] [Related]
11. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
12. Moleculary Confirmed, Cytogenetic Remission in a Case with Myelodysplastic Syndrome Treated with Azacitidne.
Panovska-Stavridis I; Ivanovski M; Trajkova S; Pivkova-Veljanovska A; Popova-Labaceska M; Matevska-Geshovska N; Noveski P; Plaseska-Karanfilska D; Cevreska L; Dimovski AJ
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Dec; 38(3):157-162. PubMed ID: 29668469
[TBL] [Abstract][Full Text] [Related]
13. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.
Vasioukhin V; Anker P; Maurice P; Lyautey J; Lederrey C; Stroun M
Br J Haematol; 1994 Apr; 86(4):774-9. PubMed ID: 7918071
[TBL] [Abstract][Full Text] [Related]
14. Late hematological improvement of myelodysplastic syndrome following treatment with 5-azacitidine therapy.
Takaoka K; Hangaishi A; Ito A; Morioka T; Kida M; Usuki K
Intern Med; 2014; 53(19):2241-3. PubMed ID: 25274238
[TBL] [Abstract][Full Text] [Related]
15. Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment.
Stosch JM; Heumüller A; Niemöller C; Bleul S; Rothenberg-Thurley M; Riba J; Renz N; Szarc Vel Szic K; Pfeifer D; Follo M; Pahl HL; Zimmermann S; Duyster J; Wehrle J; Lübbert M; Metzeler KH; Claus R; Becker H
Br J Haematol; 2018 Sep; 182(6):830-842. PubMed ID: 29974943
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndromes (MDS).
Klimek V
Best Pract Res Clin Haematol; 2015 Mar; 28(1):1-2. PubMed ID: 25659724
[No Abstract] [Full Text] [Related]
17. Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy.
Uy GL; Duncavage EJ; Chang GS; Jacoby MA; Miller CA; Shao J; Heath S; Elliott K; Reineck T; Fulton RS; Fronick CC; O'Laughlin M; Ganel L; Abboud CN; Cashen AF; DiPersio JF; Wilson RK; Link DC; Welch JS; Ley TJ; Graubert TA; Westervelt P; Walter MJ
Leukemia; 2017 Apr; 31(4):872-881. PubMed ID: 27740633
[TBL] [Abstract][Full Text] [Related]
18. FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: verification of the method and application to 27 MDS patients.
Braulke F; Schanz J; Jung K; Shirneshan K; Schulte K; Schuetze C; Steffens R; Trümper L; Haase D
Leuk Res; 2010 Oct; 34(10):1296-301. PubMed ID: 20226527
[TBL] [Abstract][Full Text] [Related]
19. Understanding the pathogenesis of myelodysplastic syndromes.
Delforge M
Hematol J; 2003; 4(5):303-9. PubMed ID: 14502253
[TBL] [Abstract][Full Text] [Related]
20. Advances in myelodysplastic syndrome: nursing implications of azacitidine.
Demakos EP; Linebaugh JA
Clin J Oncol Nurs; 2005 Aug; 9(4):417-23. PubMed ID: 16117208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
